Skip to main content

Viatris Inc

VTRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001792044

No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.7B in total; Greenlight Capital is the only superinvestor holding it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +17 vs. previous quarter
1,032
13F valueReported value at the end of Q2 2026
$16.7B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

Superinvestors holding VTRS, Q2 2026

1 superinvestor reports holding Viatris Inc on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

Greenlight Capital

David Einhorn

1.1%

Viatris Inc's share of the portfolio

Shares
2,773,470
Value
$44.0M

Latest insider trades

Open-market purchases and sales by Viatris Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 26, 2026 (view filing)Jun 251 dayCampbell PaulSee RemarksSSale−50.1K$16.17−$809.7K−13.7%316.2K after10b5-1
Mar 24, 2026 (view filing)Mar 231 dayCampbell PaulSee RemarksSSale−21.4K$13.28−$283.5K−5.5%366.3K after
Mar 10, 2026 (view filing)Aug 27-Nov 3, 2025195 daysLateSimmons David SDirectorPPurchase+499$10.42+$5.20K+73.0%1.18K after2 lots
Sep 12, 2025 (view filing)Sep 111 dayLe Goff CorinneChief Commercial OfficerSSale−7.03K$10.25−$72.1K−16.6%35.3K after10b5-1
Aug 13, 2025 (view filing)Aug 121 daySmith Scott AndrewChief Executive OfficerPPurchase+22.0K$9.99+$219.8K+7.5%314.8K after
May 14, 2025 (view filing)May 122 daysSmith Scott AndrewChief Executive OfficerPPurchase+60.0K$8.94+$536.4K+25.8%292.8K after
Nov 12, 2024 (view filing)Nov 111 dayCampbell PaulSee RemarksSSale−26.9K$12.88−$346.8K−17.5%126.9K after
Oct 25, 2024 (view filing)Dec 11, 2020-Oct 26, 20231,414 daysLateKorman HarryDirectorPPurchase+4.40K$13.91+$61.3K+4.9%95.0K after10 lots
Sep 13, 2024 (view filing)Sep 121 dayMalik RajivDirectorSSale−60.3K$11.71−$706.3K−100.0%0 after
Sep 13, 2024 (view filing)Sep 121 dayMalik RajivDirectorSSale−139.7K$11.66−$1.63M−21.6%505.8K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Viatris Inc at the end of Q2 2026; share changes are against Q1 2026.

See all 1,032 holders
Institutions holding VTRS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC96,662,102$1.53B0.07%+80,073,588+482.7%Added
BlackRock, Inc.86,019,468$1.37B0.02%+1,659,664+2.0%Added
Vanguard Capital Management LLC76,046,939$1.21B0.03%+1,330,308+1.8%Added
Davis Selected Advisers75,232,254$1.19B5.13%−2,978,937−3.8%Reduced
Price T Rowe Associates Inc68,214,436$1.08B0.11%+2,350,332+3.6%Added
Vanguard Portfolio Management LLC54,282,080$862.0M0.04%+370,843+0.7%Added
State Street Corp53,069,461$842.7M0.02%+835,762+1.6%Added
Rubric Capital Management LP34,168,743$542.6M4.98%+668,743+2.0%Added
Geode Capital Management, LLC32,807,906$520.1M0.03%+961,799+3.0%Added
Dimensional Fund Advisors LP29,970,094$476.0M0.09%−8,340,599−21.8%Reduced